Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer care crowdfunding increasingly common, but rarely successful

2.

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

3.

Researchers discover that children who survive cancer have socioeconomic challenges.

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

SBRT May Beat Brachytherapy in Prostate Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot